You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

96 Results
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
Jan 2024
Drug
Other Name(s): Faslodex®
Jan 2024
Drug
Other Name(s): Provera® (multiple brands available)
Apr 2015
Drug
Other Name(s): Tagrisso®
Jan 2024
Regimen
Intent: Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Jan 2024
Regimen
Regimen
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Neoadjuvant, Adjuvant, Palliative
Jan 2024
Regimen

Pages